table of content
1 Introduction to Research & Analysis Reports
1.1 Small Molecule Targeted Cancer Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Molecule Targeted Cancer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Molecule Targeted Cancer Therapy Overall Market Size
2.1 Global Small Molecule Targeted Cancer Therapy Market Size: 2021 VS 2028
2.2 Global Small Molecule Targeted Cancer Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Small Molecule Targeted Cancer Therapy Players in Global Market
3.2 Top Global Small Molecule Targeted Cancer Therapy Companies Ranked by Revenue
3.3 Global Small Molecule Targeted Cancer Therapy Revenue by Companies
3.4 Top 3 and Top 5 Small Molecule Targeted Cancer Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Small Molecule Targeted Cancer Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Small Molecule Targeted Cancer Therapy Players in Global Market
3.6.1 List of Global Tier 1 Small Molecule Targeted Cancer Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Small Molecule Targeted Cancer Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Small Molecule Targeted Cancer Therapy Market Size Markets, 2021 & 2028
4.1.2 Monoclonal Antibodies
4.1.3 Small Molecules
4.1.4 Small Molecule Drug Conjugates
4.2 By Type - Global Small Molecule Targeted Cancer Therapy Revenue & Forecasts
4.2.1 By Type - Global Small Molecule Targeted Cancer Therapy Revenue, 2017-2022
4.2.2 By Type - Global Small Molecule Targeted Cancer Therapy Revenue, 2023-2028
4.2.3 By Type - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Small Molecule Targeted Cancer Therapy Market Size, 2021 & 2028
5.1.2 Lymphoma
5.1.3 Melanoma
5.1.4 Multiple Myeloma
5.1.5 Breast Cancer
5.1.6 Prostate Cancer
5.1.7 Other Cancers
5.2 By Application - Global Small Molecule Targeted Cancer Therapy Revenue & Forecasts
5.2.1 By Application - Global Small Molecule Targeted Cancer Therapy Revenue, 2017-2022
5.2.2 By Application - Global Small Molecule Targeted Cancer Therapy Revenue, 2023-2028
5.2.3 By Application - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Small Molecule Targeted Cancer Therapy Market Size, 2021 & 2028
6.2 By Region - Global Small Molecule Targeted Cancer Therapy Revenue & Forecasts
6.2.1 By Region - Global Small Molecule Targeted Cancer Therapy Revenue, 2017-2022
6.2.2 By Region - Global Small Molecule Targeted Cancer Therapy Revenue, 2023-2028
6.2.3 By Region - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Small Molecule Targeted Cancer Therapy Revenue, 2017-2028
6.3.2 US Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.3.3 Canada Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.3.4 Mexico Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Small Molecule Targeted Cancer Therapy Revenue, 2017-2028
6.4.2 Germany Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.4.3 France Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.4.4 U.K. Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.4.5 Italy Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.4.6 Russia Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.4.8 Benelux Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Small Molecule Targeted Cancer Therapy Revenue, 2017-2028
6.5.2 China Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.5.3 Japan Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.5.4 South Korea Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.5.6 India Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Small Molecule Targeted Cancer Therapy Revenue, 2017-2028
6.6.2 Brazil Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.6.3 Argentina Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue, 2017-2028
6.7.2 Turkey Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.7.3 Israel Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.7.5 UAE Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
7 Players Profiles
7.1 OncoGenex Pharmaceuticals, Inc.
7.1.1 OncoGenex Pharmaceuticals, Inc. Corporate Summary
7.1.2 OncoGenex Pharmaceuticals, Inc. Business Overview
7.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Major Product Offerings
7.1.4 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue in Global Market (2017-2022)
7.1.5 OncoGenex Pharmaceuticals, Inc. Key News
7.2 Cytokinetics Inc.
7.2.1 Cytokinetics Inc. Corporate Summary
7.2.2 Cytokinetics Inc. Business Overview
7.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Major Product Offerings
7.2.4 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue in Global Market (2017-2022)
7.2.5 Cytokinetics Inc. Key News
7.3 Hospira Inc.
7.3.1 Hospira Inc. Corporate Summary
7.3.2 Hospira Inc. Business Overview
7.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Major Product Offerings
7.3.4 Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue in Global Market (2017-2022)
7.3.5 Hospira Inc. Key News
7.4 GlaxoSmithKline plc
7.4.1 GlaxoSmithKline plc Corporate Summary
7.4.2 GlaxoSmithKline plc Business Overview
7.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Major Product Offerings
7.4.4 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue in Global Market (2017-2022)
7.4.5 GlaxoSmithKline plc Key News
7.5 Boehringer Ingelheim GmbH
7.5.1 Boehringer Ingelheim GmbH Corporate Summary
7.5.2 Boehringer Ingelheim GmbH Business Overview
7.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Major Product Offerings
7.5.4 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue in Global Market (2017-2022)
7.5.5 Boehringer Ingelheim GmbH Key News
7.6 Bayer HealthCare AG
7.6.1 Bayer HealthCare AG Corporate Summary
7.6.2 Bayer HealthCare AG Business Overview
7.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Major Product Offerings
7.6.4 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue in Global Market (2017-2022)
7.6.5 Bayer HealthCare AG Key News
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Corporate Summary
7.7.2 Abbott Laboratories Business Overview
7.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Major Product Offerings
7.7.4 Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue in Global Market (2017-2022)
7.7.5 Abbott Laboratories Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
